NASDAQ: it was obvious to me when Mullholland wand
Post# of 148165
Quote:
NASDAQ: it was obvious to me when Mullholland wandered all over the place in the August meeting about what they needed to do for NASDAQ,
Almost a year ago I pointed out that one of the things that was needed for NASDAQ was either money on hand to cover a year of expenses or a credible business plan that would show how revenues would achieve that. We either borrow a large amount of money and put the intellectual property at risk, a share offering at a low stock price or wait for approval and it gets covered. There was probably an expectation of approval on mild/moderate which was dashed by the overwhelming amount of mild and asymptomatic patients.
Quote:
Second, the BLA for the FDA sounded like Cytodyn was poorly prepared .
How would Cytodyn have the foreknowledge to prepare for the FDA asking for more and more data. They certainly couldn't have foreseen the FDA asking for data that didn't even exist yet.
This particular trope is hammered on continuously as another mistake by Nader. Just another factual inaccuracy to fulfill whatever agenda they have.